MBX Biosciences, Inc.
MBX· Nasdaq
Released Nov 6, 2025, before the open
10-Q filed Nov 6, 2025, 37 days after period end · 0001193125-25-268148
| Metric | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|
| Net Income | -$21.62M | -$18.14M | -$10.16M |
| EPS Diluted | -$0.63 | -$2.78 | -$9.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MBX Biosciences, Inc. · CIK 1776111 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d after period end
+9.7% from the close of Nov 5, 2025 to the close of Nov 6, 2025, the first after the release.